Literature DB >> 24148468

Role of background observed in aptasensor with chemiluminescence detection.

Lucienne Park1, Julie Kim, Ji Hoon Lee.   

Abstract

One-step chemiluminescent aptasensor was developed using chemically initiated electron exchange luminescence (CIEEL) between high-energy intermediate formed from 1,1'-oxalyldiimidazole chemiluminescence (ODI-CL) reaction and G-quadruplex (ochratoxin A (OTA)-bound aptamer conjugated with TEX615) generated. The sensitivity of chemiluminescent aptasensor, optimized with various variables (e.g., property of microfibers fabricated with 3,4,9,10-perylenetetracarboxylic dimide, determination of fluorescent dye labeled with aptamer, physical properties of buffer solution), was dependent on the background (concentration of high-energy intermediate) generated in ODI-CL reaction. The limit of detection (LOD=background+3×standard deviation, 0.5 nM) of ODI-CL aptasensor with lower background was lower than that (3.7 nM) with 20 times higher background. Also, the ratio of signal to background (S/B) of ODI-CL aptasensor with low background was about 5-fold higher than that with high background. The sensitivities of ODI-CL aptasensors, with low as well as high background, capable of accurately and precisely quantifying OTA within 10 min, were better than those of fluorescent aptasensors and as good as those of highly sensitive but time-consuming competitive enzyme-linked immune-sorbent assays (ELISAs) using expensive antibody produced with the sacrifice of small animals.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aptamer; Aptasensor; Background; Chemiluminescence; Microfibers; Nanoparticles

Mesh:

Substances:

Year:  2013        PMID: 24148468     DOI: 10.1016/j.talanta.2013.07.072

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  1 in total

Review 1.  Advances in Optical Aptasensors for Early Detection and Diagnosis of Various Cancer Types.

Authors:  Qurat Ul Ain Zahra; Qaiser Ali Khan; Zhaofeng Luo
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.